156243-39-9

Basic information

• Product Name: 1,7,9-trimethyl-1H-imidazo[4,5-g]quinoxalin-2-amine
• Synonyms: 1,7,9-Trimethyl-1H-imidazo[4,5-g]quinoxalin-2-amine; 1H-imidazo[4,5-g]quinoxalin-2-amine, 1,7,9-trimethyl-; 2-amino-1,7,9-trimethylimidazo(4,5-g)quinoxaline
• CAS NO: 156243-39-9
• Molecular Formula: C₁₂H₁₃N₅
• Molecular Weight: 227.2651
• Mol File: 156243-39-9.mol
• Article Data: 1

Chemical Properties

• Boiling Point: 464.3°C at 760 mmHg
• Flash Point: 234.6°C
• Density: 1.42g/cm³
• Vapor Pressure: 8.48E-09mmHg at 25°C
• Refractive Index: 1.746
• CAS DataBase Reference: 1,7,9-trimethyl-1H-imidazo[4,5-g]quinoxalin-2-amine(CAS DataBase Reference)
• NIST Chemistry Reference: 1,7,9-trimethyl-1H-imidazo[4,5-g]quinoxalin-2-amine(156243-39-9)
• EPA Substance Registry System: 1,7,9-trimethyl-1H-imidazo[4,5-g]quinoxalin-2-amine(156243-39-9)

Safety Data

• Hazardous Substances Data: 156243-39-9(Hazardous Substances Data)

Usage

Explanation

Different sources of media describe the Explanation of 156243-39-9 differently. You can refer to the following data:
1. The compound is composed of 13 carbon atoms, 14 hydrogen atoms, and 4 nitrogen atoms.
2. It contains a fused imidazole and quinoxaline ring system, which are both heterocyclic in nature.
3. The imidazole ring is connected to the quinoxaline ring, forming a fused ring system.
4. The compound has an amino group (-NH2) attached to the second carbon atom of the imidazole ring.
5. The imidazole ring has three methyl groups (-CH3) attached at the 1st, 7th, and 9th positions.
6. The compound belongs to the imidazo[4,5-g]quinoxalin-2-amine family of compounds.
7. Due to its unique structure and properties, the compound has potential applications in the fields of medicinal chemistry and drug development.
8. The specific arrangement of the fused rings and functional groups in the compound may contribute to its potential for biological activity and therapeutic use.

Chemical structure

Heterocyclic compound

Imidazole ring

Fused to a quinoxaline ring

Amino group

Attached to the second carbon

Methyl groups

Three methyl groups at positions 1, 7, and 9

Family

Imidazo[4,5-g]quinoxalin-2-amine

Applications

Medicinal chemistry and drug development

Unique structure

Potential for biological activity

Upstream product

• 506-68-3 bromocyane 
• 156243-45-7 (3,5-Dimethyl-7-nitro-quinoxalin-6-yl)-methyl-amine 
• 156243-37-7 N-(3,5-Dimethyl-7-nitro-quinoxalin-6-yl)-2,2,2-trifluoro-N-methyl-acetamide 
• 156243-42-4 N-(2-Methyl-3-methylamino-6-nitro-phenyl)-acetamide 
• 156243-41-3 N-(3-Fluoro-2-methyl-6-nitro-phenyl)-acetamide 
• 156243-43-5 2,N¹-Dimethyl-4-nitro-benzene-1,3-diamine 
• 156243-44-6 2,8-dimethyl-7-methylaminoquinoxaline 
• 443-86-7 3-fluoro-2-methylaniline 

Relevant articles and documents

Synthesis and mutagenicity of a new mutagen, 2-amino-1,7,9- trimethylimidazo-[4,5-g]quinoxaline, and its analog

A new mutagen, 2-amino-1,7,9-trimethylimidazo-[4,5-g]quinoxaline (1), isolated from beef extract, was synthesized from 3-fluoro-2-methylaniline via an intermediate, 2,8-dimethyl-7-methylaminoquinoxaline (7a). Its 2- methylanalog (2) was also synthesized from the same intermediate. The synthetic 1 showed the same mutagenic activity as the isolated mutagen. However, 2 was non-mutagenic.